|
|
||||||||
Physiological Reviews, Vol. 81, No. 3, July 2001, pp. 1353-1392
Copyright ©2001 by the American Physiological Society
Howard Hughes Medical Institute and Departments of Cell Biology and Biochemistry, Duke University Medical Center, Durham, North Carolina; and Department of Biosciences, University of Kent, Canterbury, United Kingdom
I. INTRODUCTION
A. Overview of the Erythrocyte Membrane Skeleton
II. GENES, PROTEINS, AND PROTEIN INTERACTIONS
A. Spectrins
B. Ankyrins
C. Proteins That Promote Spectrin-Actin Interactions
III. PHYSIOLOGICAL FUNCTIONS
A. Overview
B. Stabilization of Cell Surface Membranes at Sites of Cell-Cell Contacts
C. Cell Sheet Morphogenesis
D. Assembly of Voltage-Gated Na+ Channel-Rich Domains in Excitable Cells
E. Targeting of Ca2-Release Channels to the Ca2+ Compartment of the ER
F. Orientation of Mitotic Spindles in Asymmetric Germ Cell Division in Drosophila
G. A Role for Protein 4.1 in Selective and Directed Membrane Protein Accumulation
IV. CLINICAL IMPLICATIONS
A. Functional Channelopathies Due to Defects in Ankyrin-Dependent Targeting
B. Use-Dependent Dystrophies of Muscle and Nerves Due to Defects in the Spectrin-Based Transcellular Mechanical Coupling Pathway
C. Abnormal Nervous System Development Due to L1 CAM Defects
V. SUMMARY AND PERSPECTIVES
| |
ABSTRACT |
|---|
|
|
|---|
Bennett, Vann and
Anthony J. Baines.
Spectrin and Ankyrin-Based Pathways: Metazoan
Inventions for Integrating Cells Into Tissues. Physiol. Rev. 81: 1353-1392, 2001.
The
spectrin-based membrane skeleton of the humble mammalian
erythrocyte has provided biologists with a set of interacting proteins
with diverse roles in organization and survival of cells in metazoan
organisms. This review deals with the molecular physiology of spectrin,
ankyrin, which links spectrin to the anion exchanger, and two
spectrin-associated proteins that promote spectrin interactions with actin: adducin and protein 4.1. The lack of essential functions for these proteins in generic cells grown in culture and the absence of
their genes in the yeast genome have, until recently, limited advances
in understanding their roles outside of erythrocytes. However,
completion of the genomes of simple metazoans and application of
homologous recombination in mice now are providing the first glimpses
of the full scope of physiological roles for spectrin, ankyrin, and
their associated proteins. These functions now include targeting of ion
channels and cell adhesion molecules to specialized compartments within
the plasma membrane and endoplasmic reticulum of striated muscle and
the nervous system, mechanical stabilization at the tissue level based
on transcellular protein assemblies, participation in epithelial
morphogenesis, and orientation of mitotic spindles in asymmetric cell
divisions. These studies, in addition to stretching the erythrocyte
paradigm beyond recognition, also are revealing novel cellular pathways
essential for metazoan life. Examples are ankyrin-dependent
targeting of proteins to excitable membrane domains in the plasma
membrane and the Ca2+ homeostasis compartment of the
endoplasmic reticulum. Exciting questions for the future relate to the
molecular basis for these pathways and their roles in a clinical
context, either as the basis for disease or more positively as
therapeutic targets.
| |
I. INTRODUCTION |
|---|
|
|
|---|
Emergence of metazoans from their unicellular ancestors required solutions to a new set of problems imposed by function of cells in the context of tissues and in motile organisms of immense size compared with individual cells. These requirements of communal life include ability of cells to develop micron-scale spatial organization of cell surfaces and of intracellular compartments to optimize cell-cell interactions and intercellular signaling. In addition, cells incorporated into an actively moving organism must deal with enormous mechanical stresses at the plasma membrane-cytoskeleton interface compared with free-living cells. Understanding the molecular basis for such metazoan adaptations represents an interdisciplinary challenge involving biochemistry, cell biology, physiology, and molecular medicine. This review focuses on the molecular physiology of spectrin and the spectrin-associated proteins ankyrin, adducin, and protein 4.1. These proteins were first discovered as components of the membrane skeleton of human erythrocytes (see below) and are required for survival of erythrocytes in the circulation. The erythrocyte membrane proteins are members of closely related families that are associated with membranes in simple metazoans, including Caenorhabditis elegans and Drosophila melanogaster, and are expressed in most vertebrate tissues. Spectrin, ankyrin, adducin, and protein 4.1 are modular proteins that are not present in their assembled state in the completed Saccharomyces cerevisea or Arabidopsis thaliana genomes and so far have not appeared in Zea mays genomic sequences. These proteins therefore are likely to have evolved early in evolution of metazoans, following divergence of plants and fungi, and represent candidates for roles in specialized activities of multicellular animals.
Recent discoveries based on studies involving C. elegans and D. melanogaster as well as gene knock-outs in mice will be reviewed that demonstrate functions of spectrin- and ankyrin-based protein assemblies in diverse roles that are all related to multicellular life. Functions that will be described include morphogenesis of epithelial tissues, targeting of ion channels and cell adhesion molecules to specialized regions in myelinated axons, and sorting of Ca2+ homeostasis proteins to the Ca2+ compartment of the endoplasmic reticulum (ER) of striated muscle. The clinical implications of these observations are only beginning to be appreciated and are discussed. Elucidation of physiological roles of spectrin and ankyrin-associated proteins is based on a strong foundation at a molecular level. The review includes current information regarding gene family members, atomic structures, oligomeric state, and protein interactions. The human erythrocyte remains the best understood in terms of its membrane skeleton, and the review begins with a brief summary of this system.
A. Overview of the Erythrocyte Membrane Skeleton
The membrane skeleton of mammalian erythrocytes was first visualized in electron micrographs of detergent-extracted erythrocytes (440). The erythrocyte membrane skeleton is organized as a polygonal network formed by five to seven extended spectrin molecules linked to short actin filaments ~40 nm in length (42, 247, 360) (Fig. 1A). The spectrin-actin network of erythrocytes is coupled to the membrane bilayer primarily by association of spectrin with ankyrin, which in turn is bound to the cytoplasmic domain of the anion exchanger (17, 20, 23, 256, 400, 441). The anion exchanger is associated into dimers (305), which associate with separate sites on the membrane-binding domain of ankyrin to form pseudo-tetramers (53, 281, 332, 437). Anion exchanger dimers also are associated on their cytoplasmic surface with band 4.2 (442). Additional membrane connections are provided at the spectrin-actin junction by a complex between protein 4.1, p55, a member of the MAGUK family, and glycophorin C (170, 266, 267) (Fig. 1B).
|
Several proteins responsible for capping actin and defining the length of actin filaments as well as stabilizing spectrin-actin complexes have been localized to spectrin-actin junctions by electron microscopy (91, 402). Protein 4.1 stabilizes spectrin-actin complexes (400, 401). Adducin associates with the fast-growing end of actin filaments in a complex that caps the filament and promotes assembly of spectrin (135, 222, 223, 239) (Fig. 1C). A nonmuscle isoform of tropomyosin is associated with the sides of actin filaments (127). Tropomyosin is of the same length as actin filaments visualized in electron micrographs and is a candidate to function as a morphometric ruler defining the length of actin filaments in erythrocyte membranes. Tropomodulin caps the slow-growing end of actin filaments in a ternary complex involving tropomyosin (124-126, 421).
Components of the erythrocyte membrane skeleton have been the subject of recent reviews or papers that include discussions of tropomodulin (125), protein 4.1 (68, 118), protein 4.2 (62), p55 (56), spectrin (164, 410), the anion exchanger, and glycophorin C (4, 381). The contributions of these proteins to mechanical properties of erythrocyte membranes have also been summarized (97, 289).
A major function of the spectrin skeleton in erythrocytes is to provide
mechanical support for the membrane bilayer and allow survival of these
cells in the circulation. The essential nature of the
spectrin-skeleton in red cell biology was first demonstrated in
mutant mice with deficiencies in
- and
-spectrin and ankyrin (33, 152). Numerous mutations have
subsequently been catalogued in humans with hereditary hemolytic
anemias. Defects in lateral associations of the spectrin-actin
network result in abnormally shaped cells in elliptocytosis and
poikilocytosis and include loss of spectrin dimer-tetramer
interactions (395) and deficiency of protein 4.1 (67, 120, 383). Defects in
membrane associations result in loss of unsupported phospholipid
bilayer and spherocytosis. Molecular defects include spectrin
deficiency from a variety of causes (1, 2,
52, 94, 112). A substantial
literature has documented naturally occurring mutations/deficiencies of
skeletal proteins resulting in hereditary hemolytic anemias in humans
and mice (reviewed in Refs. 87, 166, 396). An emerging area of interest
is mutations resulting from targeted gene knock-outs in mice
resulting in hemolytic anemias that may foreshadow human disorders. An
example is the
-adducin null mouse, which exhibits spherocytosis
(143).
| |
II. GENES, PROTEINS, AND PROTEIN INTERACTIONS |
|---|
|
|
|---|
Solution of the organization of the spectrin-based membrane skeleton of the human erythrocyte membrane has provided the biochemical equivalent of a high-resolution genetic pathway of interacting membrane structural proteins. The discovery that other tissues express isoforms of ankyrin (18) and spectrin (20, 40, 146, 151, 237, 343) suggested that the erythrocyte membrane skeleton had a broad relevance for other cell types. However, although the basic structural principles established in erythrocytes are likely to apply in other tissues, the organization, protein interactions, and functions of spectrin-based structures are considerably more diverse in other cells. Nevertheless, understanding the physiological roles of these proteins begins with their structure and biochemistry. This section focuses on genes, alternatively spliced variants, protein structure, and protein interactions of generally expressed forms of spectrin, and the proteins that interact with spectrin: ankyrin, protein 4.1, and adducin.
A. Spectrins
Spectrins are extended, flexible molecules ~200-260 nm in
length and 3-6 nm across with actin-binding domains at each end (20, 146, 362,
400). Spectrins are comprised of
- and
-subunits, which are both related to
-actinin (43,
105, 319, 387,
408). The
- and
-subunits are associated laterally
to form antiparallel heterodimers, and heterodimers are assembled
head-head to form heterotetramers (Fig.
2, Table
1).
|
|
Metazoan spectrins exhibit 50-60% sequence similarity along the length of the predicted polypeptide chains, when compared between Drosophila, C. elegans, and vertebrates, with some regions with 70-80% identity. Candidates for prototypic spectrins, possibly comprised of a single subunit, have also been characterized biochemically and by electron microscopy in Dictyostelium (16) and Acanthamoeba (336). However, sequence information is not yet available for these presumed spectrin ancestors. Spectrin subunits are absent from completed S. cerevisiae and Arabidopsis thaliana genomes, although individual domains of spectrin are represented. Similarly, no spectrin sequence has yet appeared in genome of Zea mays. Polypeptides cross-reacting with spectrin have been reported in higher plants (118, 284, 364) as well as green algae (176) and Chlamydomonas (252). However, these immunoreactive forms of spectrin have not been characterized in terms of primary sequence or visualized by electron microscopy. Definition of the full scope of the spectrin family awaits completion of genome sequencing. However, the available data demonstrate that spectrins are ancient proteins present in their modern form in simple metazoans.
The spectrin repertoire of the completed C. elegans and
D. melanogaster genomes includes one
-subunit
(105), one
-subunit (41, 159,
292), and one
-H subunit (106,
276, 387). Currently characterized spectrins
in humans include two
-subunits (
1,
2)
(353, 419), four
-subunits
(
1,
2,
3,
4) (24, 187, 261,
286, 310, 372, 427,
428), and a
-H subunit (also referred to as
5) (371) (Table 1).
-Spectrins also
include isoforms that have not been characterized at a molecular level.
NM is a
-type subunit identified at neuromuscular
junctions based on immunoreactivity (31).
Golgi-Spectrin has been discovered by Beck et al.
(9) to be an immunoreactive form of
-spectrin associated with Golgi structures.
Golgi shares epitopes
with
1-erythrocyte spectrin, but establishing the
relationship of
Golgi spectrin with other
-spectrins
will require molecular characterization. Recently,
3-spectrin has been proposed to function as the Golgi
spectrin (372). However, the pattern of expression and
cellular localization of
3-spectrin do not support a
general role in Golgi function (310).
Alternative splicing provides additional diversity among
- and
-spectrins.
I,
II, and
IV spectrins are all
differentially spliced.
I,
II, and
IV spectrins have
COOH-terminal regions that are subject to differential mRNA
splicing to generate "short" or "long" COOH-terminal
regions (24, 168, 427). The
III polypeptides described to date have a long COOH-terminal region that includes a pleckstrin homology (PH) domain (310,
372). One nomenclature refers to
-spectrin spliceoforms
by the order of their discovery (429): short
I is
I
I, and long
I is
I
II. However, this system has
become confusing as new family members have been discovered: long
IV is
IV
1 and short
IV is
IV
4, while long
II
is
II
1 and short
II is
II
2. We will refer instead
to spliceoforms by molecular weight or in some way to help describe
their domain composition.
The long COOH-terminal regions of
-spectrins have a PH domain
(see below) linked by an apparently unstructured region of ~100 amino
acid residues to the last (partial) triple helical repeat. The
polypeptide chain terminates 50-60 residues after the PH domain. Short
COOH-terminal isoforms do not contain a PH domain. About halfway
through the linker region after the last (partial) triple helical
repeat, the sequences diverge and terminate after 22-28 residues. In
both
I and
II spectrins, the short COOH-terminal region
contains multiple Ser or Thr residues that are potential substrate
sites for casein kinase II. In the case of the short
I
COOH-terminal region (i.e., in erythrocyte
-spectrin), at least
six of these residues are substrates for casein kinase II
(163, 323). As described more fully in
section IIC, the PH domain probably
represents a major ligand-binding site in
-spectrins. Thus
differential splicing modulates both the interactive and regulatory
properties of the
-spectrins.
II is subject to further differential splicing. A splice variant
termed ELF1 represents a truncated
-spectrin, consisting of little
more than a calponin homology domain (the CH1 domain) and the
COOH-terminal region of the short
II (287).
Combinatorial association of
-spectrins with various
- and
-H
subunits yields
/
and
/
-H heterotetramers with distinct functions and patterns of expression (Fig. 2, Table 1). Human
1/
1-spectrins were first characterized in
mammalian erythrocytes, and also are expressed in striated muscle and a
subset of neurons in the central nervous system (227,
300, 345). Avian erythrocytes, in contrast,
have
2/
2-spectrin (343).
2/
2,
2/
3,
and
2/
4 represent the major forms of
spectrin in nonerythroid vertebrate tissues. Terminal web spectrin
comprised of
2 and a presumed
-H spectrin are
localized in apical domains of epithelial tissues such as small
intestine, while
2/
2-spectrins are
associated with basolateral domains (147).
1. Domains
-Spectrins contain 22 domains with the following features:
domains 1-9 and 11-21 are comprised of triple helical repeats also
found in
and
-H spectrins (see below); domain 10 is an SH3 (src homology domain 3) motif; the COOH-terminal
domain 22 is related to calmodulin (393) (Figs. 2 and
3). Domain 11 of vertebrate
2-subunits contains a 35-residue extension with the cleavage site for Ca2+-activated protease and a
calmodulin-binding site (162, 235). D. melanogaster spectrin contains a predicted
calmodulin-binding site at a different position than vertebrates
(105).
|
-Spectrins contain 19 domains beginning with a highly conserved
NH2-terminal actin-binding domain comprised of two
adjacent calponin homology domains (6, 46),
followed by 17 consecutive triple-helical repeat domains and ending
with a COOH-terminal domain which includes a PH domain (Figs. 2 and
3). Ankyrin-binding sites are at a site in the midregion of the
tetramer (75, 400) and have been assigned to
repeat number 15 of
1-spectrin (210). Repeat 17 is a partial helical repeat that pairs with the COOH terminus
of
-spectrins to form a noncovalent triple-helical structure (see below).
-H spectrins of D. melanogaster (106,
387), C. elegans (276), and humans
(371) have NH2-terminal actin-binding
domains and COOH-terminal domains closely related to
-spectrins
but contain 30 triple-helical repeats instead of 17.
-H
spectrins of Drosophila and C. elegans also have
an SH3 domain inserted in the fifth triple helical domain.
-H spectrins lack an ankyrin-binding site (276, 371, 387).
A) TRIPLE-HELICAL DOMAINS. Atomic resolution of the
structure of triple-helical repeat domains obtained by X-ray
crystallography (100, 155, 434)
as well as NMR (319) provides a striking confirmation of
the structure originally predicted by Speicher and Marchesi (367). Triple helical repeats are comprised of two
parallel and one antiparallel
-helices, which are stabilized by
interactions between hydrophobic residues spaced in a heptad repeat
pattern found in other examples of paired helical structures. Tandem
triple helical repeats of spectrin and
-actinin are comprised of
antiparallel
-helices connected by an extended
-helix
(100, 155) (Fig. 3A). Comparison
of hydrodynamic properties of single and multiple domains suggests that
serial repeats are flexible and configured such that the average
end-end length is reduced compared with values predicted for rigid
rods (403). One possible source of flexibility is bending
of the
-helix interconnecting domains. A novel mechanism for
shortening end-end distances by rearrangement of helices has been
proposed by Grum et al. (155) based on alternative structures observed by crystallography. An extended series of triple
helical repeats may also exhibit a superhelical twist
(155, 274).
Spectrin repeats have recently been demonstrated by atomic force microscopy to reversibly unfold and refold when subjected to forces in the range of 35 pN (347). Spectrin and other proteins (see below) with triple helical domains therefore have the potential to function as molecular springs that can store energy and dampen deformations resulting from mechanical stress. The potential role of this elastic behavior in spectrin function is discussed below.
B) ACTIN-BINDING DOMAIN. The NH2-terminal
actin-binding domains of the
-spectrins are comprised of a pair
of calponin homology (CH) domains (47). These are similar
in sequence to a region of the smooth muscle actin-binding protein
calponin; such tandem pairs occur in other proteins that have lateral
associations with actin filaments, including dystrophin, utrophin,
-actinin, and fimbrin (Fig. 3B). Related
calponin-based actin-binding domains have been recently found in
the plakin family of proteins involved in connection of actin filaments
with intermediate filaments and microtubules (435,
436), and in cortexillins, which bundle actin filaments
(116).
X-ray crystallography has resolved the atomic structures of the
NH2-terminal (45) and COOH-terminal
(6) CH domains of
-spectrin, and of tandem CH domains
of fimbrin (149) and utrophin (291) (Fig.
3B). The tandem pairs of CH domains of fimbrin and utrophin
interact with actin, and their binding to actin filaments has been
resolved at atomic resolution (149, 161,
208, 291). The
-spectrin CH domains are
also likely to interact with actin. The actin binding activity of
-spectrin is restricted to the
-chains (44,
238). A minimal actin-binding fragment of erythrocyte spectrin has been produced by limited trypsin digestion and derives from residues 47-186 (207). These residues represent the
NH2-terminal CH domain (known as CH1), which in
utrophin and fimbrin is the highest affinity actin binding site
(161, 291).
Several considerations suggest that the site of contact with F-actin involves the junction between CH domains, with the first domain providing most of the interactions (6, 161). The second CH domain may contribute by enhancing the affinity for F-actin and/or have a regulatory role (6) (see below). Ironically, the single calponin domain of calponin itself lacks actin-binding activity (145), suggesting the likely possibility that CH domains have additional unresolved functions.
C) PH DOMAIN.
-Spectrins contain a PH domain located in
the COOH-terminal segement, which is deleted in certain
alternatively spliced isoforms (see above). These domains extend out
from spectrin rods in the midregion of spectrin tetramers and are
placed within 10 nm of each other (see Fig. 2). PH domains are
~100-residue folding units first resolved in pleckstrin, which is a
major protein kinase C substrate in platelets, and subsequently been
found in many proteins (340). A unifying feature of
proteins with PH domains is a role in signaling and proximity to plasma
membranes. Ligands for PH domains may include polyphosphatidylinositol
lipids as well as proteins.
The three-dimensional structures of the PH domains of mouse
(190, 262) and D. melanogaster
-spectrins (447) reveal similar folds to PH
domains of other proteins (340) (Fig. 3C). PH
domains include a seven-stranded
-sheet arranged as a
-barrel
with a COOH-terminal
-helix. Solution of PH domain structure
from other proteins indicates that while the overall folding of PH
domains are conserved, variations in loop lengths and composition
provide substantial variability in potential interaction surfaces
(447). Consistent with structural predictions, binding
activities of PH domains of spectrin and other proteins are distinct
both with respect to interactions with various phosphatidylinositol
lipids and to proteins (340).
D) CALMODULIN-RELATED DOMAIN.
-Spectrins contain
EF-hand motifs located at the NH2 terminus of that are
juxtaposed to the actin-binding domain on the adjacent
-subunit.
The EF-hand domain of
-spectrin shares structural homology with
calmodulin and also exhibits a Ca2+-dependent
conformational change (392, 393). An
important distinction between spectrin and calmodulin is that spectrin
only contains the two NH2-terminal EF hands and lacks the
two COOH-terminal EF hands present in calmodulin. Intact human
erythrocyte spectrin or recombinant
I or
II EF hands bind
Ca2+ selectively with a stoichiometry corresponding to the
number of EF hands but with an unphysiological affinity in the range of
hundreds of micromolar (8, 257,
258). However, intact horse spectrin molecules have been
reported to bind Ca2+ at many sites of micromolar affinity,
which presumably are not related to EF hands (414). Fowler
and Taylor (123) reported that low micromolar levels of
Ca2+ influenced human erythrocyte spectrin-actin
interactions, although spectrin-actin and spectrin-4.1-actin
interactions were described as Ca2+ insensitive by Ohanian
et al. (307). Clearly much remains to be understood about
the significance of Ca2+ binding by spectrins.
E) SH3 domain. SH3 domains,
initially observed in the Src protein tyrosine kinase, are present in
many proteins involved in cell signaling and mediate interactions with
proline-rich stretches in a variety of target proteins
(321). SH3 domains are inserted in
-spectrins (419) and in invertebrate
-H spectrins
(106, 276) (Fig. 2). The structure of the
-spectrin SH3 domain has been resolved at an atomic
level by X-ray crystallography (298) and NMR
(30, 352) (Fig. 3D). The
three-dimensional structure of spectrin SH3 domains is
a compact
-barrel and exhibits the same overall fold as other
SH3 domains.
2. Subunit interactions
Spectrin heterotetramers are assembled through the following
interactions between
- and
-subunits: 1) a lateral and
antiparallel association between
-subunits and
-subunits;
2) head-head association between laterally associated
heterodimers by linkage between partial triple-helical repeats at
the COOH-terminal end of the
-subunits and the
NH2-terminal end of
-subunits (see Fig. 2). Structural requirements for lateral association between
- and
-spectrins have been analyzed for erythrocyte (14, 368,
403) and D. melanogaster spectrin
(409, 411). The minimal domains required for
-
complexes are the first two triple-helical domains of
-spectrin and the last two triple helical domains of
-spectrin
(368). The first two triple helical domains of
-spectrin and last two of
-spectrin are closely related to the
four triple helical domains of
-actinin, which also associate
laterally in an antiparallel orientation (100). The atomic
structure of tandem
-actinin domains reveals a dimer formed
stabilized by electrostatic interactions provided by complementary
surfaces (100). Association between four triple helical
domains of
1- and
1-spectrins is of high
affinity with a dissociation constant (KD) of 10 nM (403). Further stabilization of
-
complexes is
provided by interaction between the calmodulin-related domain of
-spectrin and the calponin homology domains of
-spectrin (409, 411).
The lateral association of
- and
-spectrin subunits is highly
conserved and occurs between D. melanogaster and vertebrate spectrins (43). The high affinity of
- and
-subunits
implies that spectrin will not exist as independent
- or
-subunits but is an obligatory heterodimer or tetramer. Reports of
-spectrin unaccompanied by an
-subunit in striated muscle and at
neuromuscular junctions (31, 338) suggest the
possiblity of a heretofore unrecognized
-subunit or an
immunoreactive but otherwise highly diverged
-spectrin.
Head-to-head contacts between
- and
-spectrin subunits are
believed to occur through contacts resembling pairing between helices
in triple helical bundles (89, 211,
221, 366, 395, 433). The NH2 terminus of
-spectrin
provides one helical segment, and the COOH-terminal repeat of
-spectrin provides two antiparallel helices, with
-
pairing
resulting in a noncovalent triple helical segment. Flanking residues on
-spectrin also contribute to
-
association (55).
Defects in spectrin tetramer formation have been established in
erythrocytes of patients with hereditary elliptocytosis
(315, 395). Mutations in
- and
-spectrin defined in these patients would be predicted to disrupt
helical pairing predicted from biochemical studies (89,
396, 434). These mutations include
substitution of prolines, which would be expected to disrupt an
-helix, as well as mutations in residues predicted to provide
contacts between helices. Human mutations in the partial helical domain
of
-spectrin have been introduced into D. melanogaster
-spectrin and result in a temperature-sensitive phenotype
(89) (see below).
3. Spectrin superfamily
Proteins that contain NH2-terminal CH domains,
COOH-terminal calmodulin-related domains, and intervening triple
helical domains comprise the spectrin superfamily. Currently recognized
proteins with these combined features include
-actinins and
dystrophins. In addition, trabeculin/macrophin/MACF of vertebrates
(236) and Kakapo of D. melanogaster
(154) are newly recognized members of the plakin
family that have CH domains, 23-29 triple helical domains, and a
calmodulin-related domain, as well as domains related to plectin
and the plakin family (Fig. 4). The COOH
termini of these proteins contain a microtubule-binding domain
(206, 236). These proteins thus can interact
with actin filaments, cadherins, or integrins through the plakin domain
and microtubules. Spectrin-like repeats also are present in
eight to nine tandem copies in unc 73/kalirin/Trio, which also contain
a dbl/pleckstrin homology domain (83). Trio/Unc 73 is
required for axon pathfinding in C. elegans and D. melanogaster (259, 375).
|
Triple-helical repeats of
-actinin are most similar to the first
repeats of
-spectrin (repeats 1 and 2) and the last repeats of
-spectrin (domains 20 and 21) (43).
-Actinin thus
contains within a single polypeptide the COOH-terminal domain of
-spectrin (calmodulin-related domain and last two triple helical
repeats) and the NH2-terminal domain of
-spectrin (CH
domains and first two triple helical repeats) (Fig. 4). These
considerations have led to suggestions that
- and
-spectrins
evolved from a homodimeric
-actinin-like precursor polypeptide
(41, 319, 387,
408). One possible evolutionary scenario is that
-actinin became elongated through insertion of seven repeats by an
unspecified mechanism, followed by duplication events resulting in a
giant
-actinin-like protein. Insertion of a transcriptional promoter
within a repeat has been proposed to provide the basis for the modern
split repeat at the
-
tetramerization site and the origin of
separate
- and
-spectrin genes (387,
408).
4. Spectrin-protein interactions
A) SPECTRIN-ACTIN INTERACTION. The site of contact
of F-actin with the actin-binding domains of
-actinin
(273), fimbrin (161), and utrophin
(291) has been mapped to actin subdomains 1 and 2 as well
as subdomain 1 of the adjacent actin monomer by image analysis of
electron micrographs. These conclusions are supported by genetic
mapping of actin contact sites with fimbrin in yeast (175,
177). The fimbrin actin-binding domain induces a
conformational change in F-actin (161), suggesting the
possibility that
-spectrin could also perturb F-actin structure.
Comparison of actin-binding activities of the
-spectrin
actin-binding domain alone and with triple-helical repeats
suggests that the first triple helical repeat also participates in
spectrin-actin complexes (238) (Fig. 1C).
These results support a model where
-spectrin actually lies along
the actin filament, thus engaging in contacts involving two actin
monomers (238). Interestingly, similar studies of
dystrophin-actin interactions have concluded that lateral
associations occur between actin and dystrophin triple helical domains
(in this case repeat number 11) (351).
There is evidence that different
-spectrins exhibit varying modes of
interaction with actin. It is interesting to note that a very small
II-spectrin splice variant ELF1 (a "mini-spectrin") contains a
single CH domain that is similar to the CH1 domain of other
-spectrins. Since
1-spectrin CH1,
isolated as a tryptic fragment, binds actin avidly in vitro
(207), it is likely that ELF1 is a true actin-binding
protein, even though some other proteins with single CH domains do not
necessarily bind actin (6). Intriguingly, the
CH1 tryptic fragment of
I-spectrin appears to have
a higher affinity interaction with actin than might have been expected: it inhibits interaction of whole erythrocyte spectrin with actin with a
half-maximal effect at 5 µM, while the intact erythrocyte dimer
binds to actin with a KD of 250 µM
(309). This indicates a higher affinity interaction than
native erythrocyte
I/
I-spectrin dimer. One possibility
might be that
I-spectrin has a suppressive effect on the
interaction of
1 CH domains with actin. As we note below, the weak interaction of erythrocyte spectrin with actin is
enhanced by proteins 4.1 and adducin.
The tandem CH domains in
-spectrins may have additional roles in
actin binding. CH1, the NH2-terminal CH domain,
probably provides the primary interaction with actin (see Ref. 291).
CH2, the COOH-terminal of the pair, binds actin only
weakly (46). In utrophin, CH2 provides a
specificity for actin subtypes: utrophin binds
-actin (cytoskeletal)
with higher affinity than
-actin (sarcomeric). The CH domains of
-spectrin therefore have the potential to target spectrin to
particular isoforms of actin, as is the case with utrophin
(426). In this context, it is interesting to note that
erythrocyte membranes contain only
-actin, rather than the
-
mixture typical of most cytoskeletal systems (333).
B) SPECTRIN-MEMBRANE INTERACTIONS. Spectrins are
coupled to membranes by multiple pathways including direct association
with membrane-spanning proteins, interaction with phospholipids,
and through interactions with ankyrins (see below). Binding of spectrin to ankyrin-independent protein sites has been measured in brain membranes (80, 251, 373,
374).
-Spectrin associates with membranes through two
distinct classes of sites. One is regulated by calmodulin and is
localized in the NH2-terminal region. The other
-spectrin site is located in the COOH-terminal domain, which
includes the PH domain.
Association of the spectrin PH domain with membranes has been
demonstrated in living cells using green fluorescent protein-tagged
-spectrin PH domain (415). One class of spectrin-PH
domain interactions is likely to involve PI lipids, since the PH domain
of
1-spectrin associates with sites in brain membranes
stripped of peripheral proteins that are blocked by inositol
1,4,5-trisphosphate (IP3) and presumably represent
phosphatidylinositol sites (416).
C) SPECTRIN-ION CHANNEL INTERACTIONS. Candidates for
spectrin-binding proteins in brain synaptosomes include the
NR2 and NR1 subunits of the NMDA receptor
(422). Spectrin binds to the NR2B subunit at
sites distinct from those of
-actinin-2 and members of the
PSD95/SAP90 family. The spectrin-NR2B interactions are inhibited by Ca2+ and fyn-mediated NR2B
phosphorylation, but not by Ca2+/calmodulin or by
calmodulin kinase II-mediated phosphorylation of NR2B. The
spectrin-NR1 interactions are unaffected by
Ca2+ but inhibited by Ca2+/calmodulin and by
phosphorylation of NR1 by protein kinases A and C. The
NR1 subunit thus is a candidate to interact with the Ca2+/calmodulin-regulated site on
-spectrin
(80, 374).
Spectrin associates via the
-spectrin SH3 domain with
the
-subunit of the amiloride-sensitive Na+ channel,
EnNaC (349, 457), and with the
Na+/H+ exchanger, NHE2
(59). The amiloride-sensitive Na+
channel/spectrin complexes also contain the protein Apx, which is an
apically localized protein identified in Xenopus
(457). Association with
-spectrin may be responsible
for apical targeting of NHE2, since deletion of the
spectrin-binding loop results in basolateral localization of the
channel (59).
/
H (
TW) is the most likely form of
spectrin to associate with the apically targeted NHE2 and
amiloride-sensitive Na+ channels since
/
-spectrin
generally is localized to the basolateral domains of epithelial cells
(438).
The cGMP-gated cation channel of rod photoreceptor plasma membranes copurifies with a 240-kDa polypeptide subsequently identified as spectrin based on immunoreactivity (290). Direct linkage between spectrin and the cation channel is likely since antibodies against each protein coimmunoprecipitates the other from relatively pure preparations of the channel. The 240-kDa polypeptide was localized to the inner surface of the rod outer segment plasma membrane and excluded from the disk membranes, as would be expected for an association of this protein with the cGMP-gated cation channel in vivo.
D) SPECTRIN AS A MEMBRANE ADAPTOR FOR CYTOPLASMIC PROTEINS.
Cytoplasmic ligands for spectrin include a protein termed
HsSH3bp1 that binds to tyrosine kinases and binds to
spectrin through association with the
-spectrin SH3
domain (432, 456). HsSH3bp1 is
associated with macropinosomes and may couple spectrin to these
intracellular organelles (432). Spectrin PH domains are
likely to associate with proteins in addition to their interactions
with PI lipids (above). An interesting example is RACK1, a protein
kinase C-anchoring protein, which associates selectively with the
-spectrin PH domain and activated protein kinase C to form a ternary
complex (348).
A search for annexin VI-binding proteins revealed spectrin as one of ~14 membrane-associated proteins that associate with annexin VI in blot overlays (420). Annexin VI has subsequently been implicated in directing proteolytic degradation of spectrin during receptor-mediated endocytosis (204). The interpretation of these experiments was that annexin VI promoted proteolysis of spectrin, which resulted in relaxation of restraints of budding of a subset of coated pits. Annexin VI, according to this model, utilizes spectrin as an adaptor to direct and possibly activate a protease.
E) SPECTRIN AS A REGULATOR PROTEIN. Spectrin, at nanomolar concentrations, inhibits phospholipase D as well as phospholipases C and A2 in in vitro assays (254, 255). The basis for inhibition was most likely not a direct interaction of spectrin with these enzymes, but rather competition for their phospholipid substrates (255). Spectrin in lymphocytes associates with CD45 (192, 248), which is a member of a family of membrane-spanning glycoproteins with protein-tyrosine phosphatase activity. Spectrin binds to CD45 with a nanomolar affinity and upregulates the tyrosine phosphatase activity of CD45 (248).
B. Ankyrins
Ankyrin in human erythrocytes provides a high-affinity link between the cytoplasmic domain of the anion exchanger and the spectrin/actin network (Fig. 1). The ankyrin family has a general role as an adapter between a variety of integral membrane proteins and the spectrin skeleton. The C. elegans genome contains a single ankyrin gene, (312), whereas the D. melanogaster genome has two ankyrin genes, Dank1 and Dank2 (35, 110). The ankyrin gene family of mammals currently includes three members: ankyrin-R (R for restricted; also termed ankyrin1) (229, 260), first characterized in erythrocytes, (227); ankyrin-B (B for broadly expressed, also termed ankyrin 2) first characterized in brain (313); and ankyrin-G (G for general or giant; also termed ankyrin 3) independently discovered in searches for components of the node of Ranvier (219) and for epithelial ankyrins (93, 327, 385). Ankyrins are expressed in most tissues, and in many cases all three ankyrins are found in the same cell type.
Diseases of humans attributed to ankyrins include hereditary spherocytosis, which can result from decreased expression and/or mutated forms of ankyrin-R (112). In mice, a similar disorder (the nb/nb mutation) results in a nearly complete deficiency of 210-kDa isoforms of ankyrin-R in erythrocytes, neurons, and striated muscle (452) with a phenotype of severe anemia (33) and degeneration of a subset of Purkinje cell neurons accompanied by cerebellar dysfunction (326). Ankyrin mutations in C. elegans result in the unc44 phenotype, which includes abnormal axon guidance and uncoordinated movements (312).
1. Domains
Ankyrins are modular proteins comprised of three domains conserved among family members as well as specialized domains found in alternatively spliced isoforms (see Fig. 5). Conserved domains are an NH2-terminal membrane-binding domain, a 62-kDa spectrin-binding domain, and a 12-kDa death domain. The membrane-binding domains are comprised of 24 copies of a 33-residue repeat known as the ANK repeat that is involved in protein recognition in many types of proteins (34, 359) (Fig. 6). The 24 ANK repeats form 4 subdomains, each comprised of the basic folding unit of 6 repeats (280). The role of six-repeat subdomains as protein binding sites is discussed below. Death domains were first reported in proteins such as Fas and the tumor necrosis factor receptor that participate in apoptosis pathways (394). These domains can associate with related death domains in other proteins. The protein interactions of the ankyrin death domain could involve self-association and/or interactions with other proteins and are not yet resolved. The death domain is followed by a regulatory domain subject to alternative splicing that in the case of ankyrin-R modulates both binding of the anion exchanger and of spectrin (81, 157). A regulatory function for this domain has not been demonstrated for ankyrin-B or ankyrin-G. However, the COOH-terminal domains are the most divergent among ankyrin family members and are likely to have distinct functions that are yet to be defined.
|
|
2. Diversity due to alternative splicing
Ankyrin genes are expressed and processed in a complex tissue-dependent and developmentally regulated fashion, giving rise to a large number of isoforms that utilize different combinations of functional domains. For example, alternative splicing generates ankyrin-G isoforms missing all or portions of their membrane-binding domain (93, 178, 219, 327). Alternate exon usage is also used to generate an unusual isoform of ankyrin-R in striated muscle. This isoform lacks both the membrane-binding and spectrin-binding domains and contains only the COOH-terminal 26 kDa plus a hydrophobic stretch (452). The functions of these small ankyrins are likely to involve intracellular as opposed to plasma membrane roles, since these truncated ankyrins are associated with Golgi, lysosomal, and sarcoplasmic reticulum membranes (11, 88, 92, 452).
Ankyrin-B and ankyrin-G spliceoforms also include polypeptides with insertions of up to 2,500 amino acid residues and molecular mass of up to 480 kDa, which are abundantly expressed in axons (49, 219, 224, 225) (see below). The inserted sequences in both genes are placed between the spectrin-binding and death domains (see Fig. 5). Ankyrin-G polypeptides of 270 and 480 kDa contain inserted sequences beginning with a serine/threonine-rich stretch of ~400 residues, that is followed by sequence with similarity to that of the inserted sequence of 440-kDa ankyrin-B. The 270-kDa ankyrin-G lacks a 190-kDa stretch of this sequence resulting from the use of an alternate splice donor site.
Much of the 220-kDa inserted sequence of 440-kDa ankyrin-B has the configuration of an extended random coil based on physical properties of expressed polypeptides (49). Because the alternatively spliced insert of ankyrin-G has a highly polar hydrophilicity profile similar to that of ankyrin-B, it is likely that the 480-kDa ankyrin-G also contains an extended stretch of random coil inserted between its spectrin-binding and death domains. The properties of the inserted sequences suggest a structural model for 440-kDa ankyrin-B and 480-kDa ankyrin-G where the membrane-associated head domain is separated from the death domain by an extended filamentous tail domain encoded by the inserted sequence (see Fig. 5). The length of the tail domain could be up to 0.5 µm if fully extended, which is a distance that, in principle, could be resolved in the light microscope.
Ankyrin isoforms possessing the tail domain are highly localized to axons, whereas isoforms lacking this domain are localized to the neuron cell body (49, 224). Possible functions of the tail domains include axonal targeting motifs, deregulation of ankyrin membrane-binding domains by physical separation from the regulatory domain, and long-range connections between molecules interacting with the death domain/COOH-terminal domains and membrane-binding domains. Given the potential distance spanned by the inserted sequence, these putative ankyrin-binding molecules could be in distinct membrane domains or even different cellular compartments.
3. Ankyrin-binding membrane proteins
A defining feature of the ankyrin family is their ability to
interact through the membrane-binding domain with structurally diverse proteins with apparently unrelated primary sequences. Currently
identified ion channels/pumps that associate with ankyrin and
colocalize in cells include anion exchanger isoforms (AE1, AE2, AE3)
(22, 23, 196, 293),
the Na+-K+-ATPase (216,
297, 304), the voltage-dependent
Na+ channel (263, 269), and the
Na+/Ca2+ exchanger (240).
IP3 receptor and ryanodine receptor
Ca2+-release channels also associate with ankyrins
(36, 37, 199). Evidence for an
in vivo interaction between ankyrin-B and Ca2+ release
channels is based on altered targeting of these proteins in striated
muscle of ankyrin-B-deficient mice (397) (see below). Finally, ankyrin also associates with cell adhesion molecules (CAMs)
including CD44 (203, 249) and the L1 CAM
family (L1/neurofascin/NrCAM/CHL1/NgCAM) (76,
79, 107, 182, 450).
Evidence for physiologically important interactions between ankyrins
and L1 CAMs include downregulation of L1 in axons of ankyrin-B
(
/
) mice (358), and reduction of Dank2 in cell bodies
of neurons of neuroglian mutant flies (35).
The ankyrin membrane-binding domain also interacts with cytoplasmic proteins including tubulin (19, 75, 82) and clathrin (283). Ankyrin associates with microtubules with a relatively low affinity in the micromolar range, and the physiological significance of this interaction remains to be determined. However, ankyrin association with clathrin occurs with a KD in the nanomolar range and is specific for the fourth subdomain of ankyrin and the terminal knob domain of clathrin. Evidence that ankyrin-clathrin interactions are functionally important is that microinjection of the fourth subdomain inhibits receptor-mediated endocytosis of low-density lipoprotein (283).
The basis for diversity of binding partners for the ankyrin
membrane-binding domains is due to special properties of the
ankyrin repeats, a motif which mediates protein recognition for a large number of proteins including the transcription factors GABP-
, Nf
/I
B, and SwI 6, p53 binding protein and p16 cyclin inhibitor (reviewed in Ref. 359). Atomic structures for these proteins reveal
that ankyrin repeats are folded into a series of antiparallel
-helices connected by loops that are arranged perpendicular to the
helices (Fig. 6). Residues located at the tips of the loops are the
most variable between repeats and contain recognition sites for diverse
proteins. The four repeat subdomains of ankyrins each have distinct
binding properties, and these subdomains also cooperate with each other
to generate a further level of diversity (281,
282). An additional feature of ankyrin is that binding interactions can occur simultaneously with different membrane proteins,
resulting in multiprotein complexes (281,
282).
Sites of ankyrin interactions have been evaluated for the erythrocyte anion exchanger (AE1) (78, 96, 424), the Na+-K+-ATPase (197, 453), and the L1 CAM family (181, 450). A general conclusion from these studies is ankyrin is capable of structurally distinct interactions with diverse proteins. This conclusion is reinforced by the fact that ankyrin has independent binding sites for AE1 and L1 CAMs (281, 282). Another conclusion from analysis of ankyrin-binding sites of the Na+-K+-ATPase (450) and L1 CAMs (450) is that ankyrin-binding sites of these proteins share a conformation as a random coil even though they lack obvious sequence similarity. An ankyrin-membrane protein complex has not yet been resolved at an atomic level, but these considerations suggest a model where random coils of at least certain ankyrin-binding proteins associate with loops of ankyrin repeats (see above) (450). Given that ankyrin repeats fold into subdomains, it is likely that loops of ankyrin repeats in different subdomains also could collaborate to create a "binding pocket."
Cytoplasmic domains of the erythrocyte anion exchanger (5) and neurofascin (450) are both dimers in solution. Considered together with the finding that ankyrin has two binding sites for neurofascin as well as for two sites for the anion exchanger, the existence of dimers implies that these proteins and ankyrin are capable of forming oligomeric complexes. One predicted configuration of the anion exchanger/ankyrin complex at low ratios of ankyrin to the anion axchanger is as a pseudo-anion exchanger tetramer with two dimers independently associated with distinct sites on the ankyrin membrane-binding domain (281). Evidence that such an arrangement occurs in erythrocyte membranes is provided by observations that the anion exchanger behaves as a mixture of dimers and tetramers in native membranes and only as a dimer in ankyrin-deficient membranes (439). One could also imagine that at higher ankyrin-to-membrane protein ratios it would be possible to form linear arrays of dimeric membrane proteins cross-linked by the multivalent ankyrin membrane-binding domain. These complexes could be further immobilized by coupling to the spectrin-based membrane skeleton through the spectrin-binding domain of ankyrin. Ability to form such large immobilized complexes between ankyrin and neurofascin could be important for the assembly of specialized membrane domains such as axon initial segments and nodes of Ranvier where these proteins are localized (see below).
A) L1 CAMS AS GENERAL CORECEPTORS FOR ANKYRINS. The major class of ankyrin-binding proteins in mammalian brain is a group of CAMs in the Ig/FnIII superfamily known as L1 CAMs. These molecules together comprise over 1% of the membrane protein in adult brain tissue and are abundantly expressed on axons in the developing nervous system (reviewed in Ref. 181). The L1 CAM family of cell adhesion molecules in the vertebrate nervous system is comprised of L1, NgCAM, NrCAM, CHL1, and neurofascin, in D. melanogaster by neuroglian (181), and in C. elegans by LAD1 (L. Chen and V. Bennett, unpublished data). L1 CAMs possess variable extracellular domains comprised of six Ig and three to five fibronectin type III domains, along with a relatively conserved cytoplasmic domain (181). Extracellular domains of L1 CAMs participate in homophilic interactions as well as a variety of interactions with soluble proteins and other CAMs (39, 121, 350). Extensive diversity in extracellular interactions of L1 CAM family members is provided by divergence between extracellular domains encoded by different genes as well as multiple alternatively spliced variants of each gene (as many as 50 estimated in the case of neurofascin) (165). Consistent with the diverse extracellular domains, a range of functions has been attributed to the L1 CAM family, including axon fasciculation, axonal guidance, neurite extension, a role in long-term potentiation, synaptogenesis, and myelination (39).
Analysis of LAD-1, the single L1 CAM gene in C. elegans, has provided a global view of the pattern of expression in a metazoan and suggests a general expression at sites of cell-cell contact early in embryonic development and in essentially all cell types (Chen and Bennett, unpublished data). LAD-1 binds to GFP-tagged worm ankyrin (unc44) in cultured cells and colocalizes with ankyrin in most cell types. These findings suggest that LAD-1 is the major receptor for ankyrin (unc-44) in the worms. Given that ankyrin is multivalent with respect to neurofascin and the anion exchanger (282), it is possible that ankyrin forms heterocomplexes with LAD-1 and various ion channels (see Fig. 7 for an example of vertebrate L1 CAM/Na+ channel complexes).
|